US Patent Issued to IREGENE THERAPEUTICS on March 31 for "Neural stem cell-induced differential medium and induction differentiation method" (Chinese Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,954, issued on March 31, was assigned to IREGENE THERAPEUTICS Co. LTD. (Chengdu, China).

"Neural stem cell-induced differential medium and induction differentiation method" was invented by Jun Wei (Wuhan, China), Meng Cai (Wuhan, China), Lumeng Niu (Wuhan, China), Jia Zhou (Wuhan, China) and Mengying Hou (Wuhan, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Use of a TGF-Beta small molecule inhibitor in the field of nerve regeneration, for in vitro regeneration and directed differentiation of a variety of nerve cells and brain-like organs. By adding the TGF-Beta small molecule inhibitor to a set of basal media having clear chemical compositio...